The insurer argued the policyholder had suppressed the condition of psoriasis in her proposal form and hence was not entitled to the claim. After hearing the arguments, the commission stated ...

Icotrokinra had more significant improvements than placebo for multiple skin clearance measures following 16 weeks of treatment for plaque psoriasis in adolescents and adults. Icotrokinra is ...

Many people who have psoriasis will experience the telltale sign of itchiness or burning. But for people with differing skin tones, that’s where the similarities may end. The symptoms of ...

Utah's Escapod already builds some of the market's sleekest composite teardrop trailers. Now it's turning its attention to offering a trailer tailored to the needs of mountain bikers, ebikers and ...

This is why tiny teardrop campers are becoming wildly popular, but these minuscule size trailers usually come with some huge drawbacks. This is where the like the Escapod Topo2 and its latest ...

My favourite song is ‘Every Teardrop is a Waterfall.’” She was upset about missing Coldplay’s previous world tour and said this time is a dream come true. “Actually, I used to study in ...

EC president Ursula von der Leyen is scheduled to hold a call with the European pharmaceuticals industry. Credit: VYACHESLAV OSELEDKO via Getty Images. European Commission (EC) President Ursula von ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. The singer, one half of the folk-rock duo Simon & Garfunkel, has teamed with Sun Pharma to discuss how ...

If a person has moderate or severe psoriasis and a doctor believes drug therapy is medically necessary, Medicare can generally help cover the cost. Possible covered medications include ...

Obesity was linked to reduced long-term effectiveness of biologic therapy in patients with severe plaque psoriasis in a study, with dysregulated innate immune responses contributing to treatment ...

In your practice, what are the rates of persistence and adherence to plaque psoriasis treatment, and what key factors influence these outcomes?

The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) who have not responded to conventional systemic therapies. This ...